These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34114687)

  • 1. Familial progressive hyper- and hypopigmentation caused by a novel mutation in site II of the KITLG gene.
    Liu Z; Zhu Z; Luo J; Yang B
    J Dermatol; 2021 Sep; 48(9):e462-e463. PubMed ID: 34114687
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel mutation in the KITLG gene in familial progressive hyperpigmentation with or without hypopigmentation.
    Kato M; Yagami A; Tsukamoto T; Shinkai Y; Kato T; Kurahashi H
    J Dermatol; 2020 Jun; 47(6):669-672. PubMed ID: 32189379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo mutation in KITLG gene causes a variant of Familial Progressive Hyper- and Hypo-pigmentation (FPHH).
    Gorenjak M; Fijačko N; Bogomir Marko P; Živanović M; Potočnik U
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1841. PubMed ID: 34716665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of a child with sporadic familial progressive hyper- and hypopigmentation caused by a novel KITLG mutation.
    Zhang J; Cheng R; Liang J; Ni C; Li M; Yao Z
    Br J Dermatol; 2016 Dec; 175(6):1369-1371. PubMed ID: 27106731
    [No Abstract]   [Full Text] [Related]  

  • 5. KITLG mutations cause familial progressive hyper- and hypopigmentation.
    Amyere M; Vogt T; Hoo J; Brandrup F; Bygum A; Boon L; Vikkula M
    J Invest Dermatol; 2011 Jun; 131(6):1234-9. PubMed ID: 21368769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel mutation in the KITLG gene in a Chinese family with familial progressive hyper- and hypopigmentation.
    Wang J; Li W; Zhou N; Liu J; Zhang S; Li X; Li Z; Yang Z; Sun M; Li M
    BMC Med Genomics; 2021 Jan; 14(1):12. PubMed ID: 33407466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial progressive hyperpigmentation and hypopigmentation without KITLG mutation.
    Zeng L; Zheng XD; Liu LH; Fu LY; Zuo XB; Chen G; Wang PG; Yang S; Zhang XJ
    Clin Exp Dermatol; 2016 Dec; 41(8):927-929. PubMed ID: 27859606
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial progressive hyper- and hypopigmentation and malignancy in two families with new mutations in KITLG.
    Cuell A; Bansal N; Cole T; Kaur MR; Lee J; Loffeld A; Moss C; O'Donnell M; Takeichi T; Thind CK; McGrath JA
    Clin Exp Dermatol; 2015 Dec; 40(8):860-4. PubMed ID: 26179221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetic determination of skin pigmentation: KITLG and the KITLG/c-Kit pathway as key players in the onset of human familial pigmentary diseases.
    Picardo M; Cardinali G
    J Invest Dermatol; 2011 Jun; 131(6):1182-5. PubMed ID: 21566575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial progressive hyper- and hypopigmentation: a report on a Chinese family and evidence for genetic heterogeneity.
    Xiao-Kai F; Yue-Xi H; Yan-Jia L; Li-Rong C; He-Peng W; Qing S
    An Bras Dermatol; 2017; 92(3):329-333. PubMed ID: 29186243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biallelic KITLG variants lead to a distinct spectrum of hypomelanosis and sensorineural hearing loss.
    Vona B; Schwartzbaum DA; Rodriguez AA; Lewis SS; Toosi MB; Radhakrishnan P; Bozan N; Akın R; Doosti M; Manju R; Duman D; Sineni CJ; Nampoothiri S; Karimiani EG; Houlden H; Bademci G; Tekin M; Girisha KM; Maroofian R; Douzgou S
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1606-1611. PubMed ID: 35543077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical phenotype and genetic analysis of a Chinese pedigree affected with familial progressive hyperpigmentation and hypopigmentation].
    Xu Z; Su Z; Zheng R; Hou L; Zhang L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Dec; 39(12):1360-1365. PubMed ID: 36453959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper- and hypopigmented macules over palms and soles since birth--a case of dyschromatosis symmetrica hereditaria.
    Hemmati I; Lam J
    Dermatol Online J; 2009 Nov; 15(11):5. PubMed ID: 19951641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial progressive hypo- and hyperpigmentation: a variant case.
    Zhang RZ; Zhu WY
    Indian J Dermatol Venereol Leprol; 2012; 78(3):350-3. PubMed ID: 22565436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticulate acropigmentation of dohi: first case reports from Nepal.
    Agarwalla A; Agrawal S; Rijal A; Barman KD; Bhattarai S
    J Dermatol; 2003 Oct; 30(10):748-50. PubMed ID: 14684959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive familial hyperpigmentation is associated with mutations activating the KIT receptor ligand].
    Dereure O
    Ann Dermatol Venereol; 2010 Mar; 137(3):247. PubMed ID: 20227574
    [No Abstract]   [Full Text] [Related]  

  • 17. Oculocutaneous albinism.
    Goldberg RA; Lally DR; Heier JS
    JAMA Ophthalmol; 2015 Mar; 133(3):e143518. PubMed ID: 25763554
    [No Abstract]   [Full Text] [Related]  

  • 18. Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)--does hypermelanotic or hypomelanotic skin status of affected patients play a role?
    Bakare MO
    Med Hypotheses; 2011 May; 76(5):673-5. PubMed ID: 21288648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear and whorled pigmentation.
    Harre J; Millikan LE
    Int J Dermatol; 1994 Aug; 33(8):529-37. PubMed ID: 7960343
    [No Abstract]   [Full Text] [Related]  

  • 20. Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation.
    Wang ZQ; Si L; Tang Q; Lin D; Fu Z; Zhang J; Cui B; Zhu Y; Kong X; Deng M; Xia Y; Xu H; Le W; Hu L; Kong X
    Am J Hum Genet; 2009 May; 84(5):672-7. PubMed ID: 19375057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.